Daridorexant is a dual orexin receptor antagonist being developed by Nxera for the treatment of adult patients with insomnia and…
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation BTK protein degrader APG-3288 receives…
- Rapidly transforming into a leading global biopharma company January 09, 2026 18:01 ET | Source: Ascendis Pharma COPENHAGEN, Denmark,…
January 05, 2026 11:05 ET | Source: Zealand Pharma Press release – No. 1 / 2026 Zealand Pharma to present…
December 31, 2025 11:05 ET | Source: Zealand Pharma Company announcement – No. 27 / 2025 Total number of shares…
Introduction of AVT05 supported by NHS England tender award in the United Kingdom REYKJAVIK, Iceland, Dec. 22, 2025 (GLOBE NEWSWIRE)…
New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism…
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE…
HYDERABAD, India, Nov. 21, 2025 /PRNewswire/ -- HRV Global Life Sciences (HRV Pharma), India's first integrated Virtual API and Pharmtech…
The Summit highlights how collaboration, trust, and digital innovation are shaping India's evolution into a global pharma powerhouse committed to…